Donga Socio Holdings - Asset Resilience Ratio

Latest as of June 2025: 1.85%

Donga Socio Holdings (000640) has an Asset Resilience Ratio of 1.85% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩37.95 Billion
≈ $25.72 Million USD Cash + Short-term Investments

Total Assets

₩2.05 Trillion
≈ $1.39 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2000–2024)

This chart shows how Donga Socio Holdings's Asset Resilience Ratio has changed over time. Check Donga Socio Holdings strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Donga Socio Holdings's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 000640 market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩37.95 Billion 1.85%
Total Liquid Assets ₩37.95 Billion 1.85%

Asset Resilience Insights

  • Limited Liquidity: Donga Socio Holdings maintains only 1.85% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Donga Socio Holdings Industry Peers by Asset Resilience Ratio

Compare Donga Socio Holdings's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
Drug Manufacturers - Specialty & Generic 20.44%
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
Drug Manufacturers - Specialty & Generic 48.48%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 11.69%
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
Drug Manufacturers - Specialty & Generic 4.31%
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211
Drug Manufacturers - Specialty & Generic 15.57%
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
Drug Manufacturers - Specialty & Generic 24.59%
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
Drug Manufacturers - Specialty & Generic 18.70%

Annual Asset Resilience Ratio for Donga Socio Holdings (2000–2024)

The table below shows the annual Asset Resilience Ratio data for Donga Socio Holdings.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.49% ₩9.95 Billion
≈ $6.75 Million
₩2.03 Trillion
≈ $1.38 Billion
-1.59pp
2023-12-31 2.08% ₩40.64 Billion
≈ $27.54 Million
₩1.96 Trillion
≈ $1.33 Billion
+1.46pp
2022-12-31 0.61% ₩10.63 Billion
≈ $7.20 Million
₩1.73 Trillion
≈ $1.17 Billion
-2.86pp
2021-12-31 3.48% ₩58.84 Billion
≈ $39.87 Million
₩1.69 Trillion
≈ $1.15 Billion
-0.21pp
2020-12-31 3.68% ₩55.67 Billion
≈ $37.73 Million
₩1.51 Trillion
≈ $1.02 Billion
-0.35pp
2019-12-31 4.03% ₩54.81 Billion
≈ $37.14 Million
₩1.36 Trillion
≈ $920.69 Million
+3.56pp
2018-12-31 0.48% ₩5.93 Billion
≈ $4.02 Million
₩1.24 Trillion
≈ $841.64 Million
+0.40pp
2017-12-31 0.08% ₩1.11 Billion
≈ $749.55K
₩1.46 Trillion
≈ $989.05 Million
-0.10pp
2016-12-31 0.17% ₩2.43 Billion
≈ $1.65 Million
₩1.40 Trillion
≈ $950.26 Million
-0.13pp
2015-12-31 0.30% ₩3.70 Billion
≈ $2.51 Million
₩1.22 Trillion
≈ $829.16 Million
+0.09pp
2014-12-31 0.21% ₩2.25 Billion
≈ $1.52 Million
₩1.08 Trillion
≈ $732.63 Million
-0.52pp
2013-12-31 0.73% ₩7.20 Billion
≈ $4.88 Million
₩988.28 Billion
≈ $669.74 Million
+0.52pp
2012-12-31 0.21% ₩3.59 Billion
≈ $2.43 Million
₩1.72 Trillion
≈ $1.17 Billion
-2.77pp
2011-12-31 2.98% ₩44.45 Billion
≈ $30.12 Million
₩1.49 Trillion
≈ $1.01 Billion
+2.16pp
2010-12-31 0.82% ₩10.09 Billion
≈ $6.84 Million
₩1.23 Trillion
≈ $836.45 Million
+0.66pp
2009-12-31 0.16% ₩1.69 Billion
≈ $1.14 Million
₩1.06 Trillion
≈ $716.50 Million
-0.43pp
2008-12-31 0.59% ₩4.52 Billion
≈ $3.06 Million
₩769.94 Billion
≈ $521.78 Million
-0.37pp
2007-12-31 0.96% ₩6.83 Billion
≈ $4.63 Million
₩713.72 Billion
≈ $483.68 Million
+0.05pp
2006-12-31 0.91% ₩6.62 Billion
≈ $4.49 Million
₩731.74 Billion
≈ $495.89 Million
-0.35pp
2005-12-31 1.25% ₩9.08 Billion
≈ $6.15 Million
₩724.29 Billion
≈ $490.84 Million
+0.04pp
2004-12-31 1.21% ₩8.56 Billion
≈ $5.80 Million
₩706.01 Billion
≈ $478.45 Million
-1.10pp
2003-12-31 2.31% ₩15.98 Billion
≈ $10.83 Million
₩691.41 Billion
≈ $468.56 Million
+0.08pp
2002-12-31 2.23% ₩13.18 Billion
≈ $8.93 Million
₩590.72 Billion
≈ $400.32 Million
-2.21pp
2001-12-31 4.44% ₩26.35 Billion
≈ $17.86 Million
₩593.63 Billion
≈ $402.30 Million
+0.49pp
2000-12-31 3.95% ₩21.63 Billion
≈ $14.66 Million
₩547.36 Billion
≈ $370.94 Million
--
pp = percentage points

About Donga Socio Holdings

KO:000640 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$384.83 Million
₩567.85 Billion KRW
Market Cap Rank
#13451 Global
#384 in Korea
Share Price
₩88200.00
Change (1 day)
+2.80%
52-Week Range
₩75800.00 - ₩122800.00
All Time High
₩215705.22
About

Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of S… Read more